To complete our JUNE - IMMUNOTHERAPY theme, I am replaying a previous interview with Dr Horst Lindhoffer,PhD, one of the creators of an innovative platform of immunotherapies. Since this interview was first broadcast, there have been some company changes for production of these antibodies & new web resources can be found below. It is very relevant to inform patients & health professionals about any immunotherapies in current use, as many immunotherapies are still in trial. The trifunctional antibody Removab; is a member of the Triomab® family of antibodies which are able to treat a wide range
|